[ESKETAMINE FOR TREATMENT RESISTANT DEPRESSION: RESEARCH AND RISK MANAGEMENT].

Marom, Adi; Rosca, Paola

Marom, Adi; Rosca, Paola.

Affiliation

Marom A; The Hebrew University and Hadassah Medical School, Jerusalem, Israel.
Rosca P; Department for the Treatment of Substance Abuse, Israel Ministry of Health, Jerusalem, Israel.

Harefuah ; 160(6): 372-376, 2021 Jun.

Article in He | MEDLINE | ID: mdl-34160154

Subject(s)

Depressive Disorder, Treatment-Resistant; Ketamine; Administration, Intranasal; Depression/drug therapy; Depressive Disorder, Treatment-Resistant/drug therapy; Humans; Ketamine/adverse effects; Risk Management

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Treatment-Resistant / Ketamine Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: He Journal: Harefuah Year: 2021 Document type: Article Affiliation country: Israel Country of publication: Israel

Search on Google

Add to My VHL

XML

PubMed Links